Quantcast

Latest Hydrocodone Stories

2014-04-29 12:33:30

STAMFORD, Conn., April 29, 2014 /PRNewswire/ -- Purdue Pharma L.P. will present results from a number of research studies at the American Pain Society (APS) 33(rd) Annual Scientific Meeting, April 30-May 3, 2014, in Tampa, Fla. Following is a schedule of select poster presentations: Authors Date / Time Title...

2014-04-24 08:33:04

SAN DIEGO, April 24, 2014 /PRNewswire/ -- We at Zogenix have reviewed the letter to Vermont Governor Peter Shumlin signed by the Center for Lawful Access and Abuse Deterrence (CLAAD), The American Academy of Pain Management and the National Fibromyalgia & Chronic Pain Association, which asks the Governor and health commissioner to participate in a "multi-lateral meeting to develop a more thorough approach" to stemming Vermont's prescription drug abuse epidemic. We agree with and...

2014-04-23 08:31:19

SAN DIEGO, April 23, 2014 /PRNewswire/ -- Zogenix will continue to work to ensure patients suffering from severe chronic pain have access to the FDA-approved medications they need in every state nationwide, including Massachusetts. We are once again disappointed that Governor Patrick would issue another immediate restriction without first accepting our offer to discuss the facts and work together to address the needs of patients while combating abuse and addiction. We fully support...

Codeine Prescriptions To Children In The ER Continue Despite Dangers
2014-04-21 10:36:30

Lawrence LeBlond for redOrbit.com - Your Universe Online Codeine, or 3-methylmorphine, is an opioid that is used to treat mild to moderate pain and to suppress cough. While it is widely prescribed to adults, it is of great concern that US emergency rooms continue to prescribe it to children, despite its potentially harmful effects. A report published in the May issue of the journal Pediatrics, offers some solutions to this dangerous practice. Solutions include provider prescription...

2014-04-15 16:28:26

SAN DIEGO, April 15, 2014 /PRNewswire/ -- Zogenix, Inc. (Nasdaq: ZGNX), a pharmaceutical company developing and commercializing products for the treatment of pain-related and central nervous system (CNS) disorders, today announced that the U.S. District Court in Massachusetts entered an order, preventing the implementation of the Commonwealth's ban of Zohydro(TM) ER on Constitutional grounds. This order will become effective on April 22, 2014. The court decision today supports the...

2014-04-11 08:24:52

SAN DIEGO, April 11, 2014 /PRNewswire/ -- Rampant misinformation about Zohydro(TM) ER continues to be reported by the media and echoed in Washington D.C. and some states' capitals. These inaccurate and misleading statements are often made without proper context, and are intended to be sensational, to create fear, or to generate headlines. In many instances, these statements are not supported by scientific facts or medical evidence. Let's get the facts straight Zohydro ER is the first and...

2014-04-08 20:21:36

SAN DIEGO, April 8, 2014 /PRNewswire/ -- Today Zogenix presented its case in U.S. District Court in Boston requesting an immediate order staying the ban on the U.S. Food and Drug Administration (FDA)-approved prescription drug product, Zohydro(TM) ER (hydrocodone bitartrate) extended-release capsules (CII), entered on March 27, 2014, by Massachusetts Governor Deval Patrick. Zogenix appreciates the opportunity to be heard by the court on an expedited basis. A follow-up hearing has been...

2014-04-07 16:25:34

Company Files for Injunction - Prescription Drug Status Should Reside Solely With the FDA SAN DIEGO, April 7, 2014 /PRNewswire/ -- Zogenix, Inc. (Nasdaq: ZGNX), a pharmaceutical company developing and commercializing products for the treatment of pain-related and central nervous system (CNS) disorders, today filed a lawsuit in the U.S. District Court in Massachusetts requesting the court to grant a temporary restraining order against execution of the executive order recently announced by...

2014-04-04 16:23:31

Review of published literature points to need for physician monitoring, awareness of patient overuse of acetaminophen STAMFORD, Conn., April 4, 2014 /PRNewswire/ -- A review of published medical literature has found that individuals who receive pain relievers containing acetaminophen are commonly prescribed doses close to or above the U.S. Food & Drug Administration's (FDA) recommended daily maximum dose (4g per day), putting them at increased risk of acetaminophen overdose and liver...

2014-04-04 08:25:20

SAN DIEGO, April 4, 2014 /PRNewswire/ -- Today, Health and Human Services (HHS) Secretary Kathleen Sebelius, and U.S. Food and Drug Administration (FDA) Commissioner Dr. Margaret Hamburg, called for a balanced approach in the fight against prescription drug abuse and preserving the protection of the needs and rights of patients suffering from severe chronic pain. It was an impressive showcase of a unified front and a call for all stakeholders to help at every level. It is vitally important...


Word of the Day
toccata
  • In music, a work for a keyboard-instrument, like the pianoforte or organ, originally intended to utilize and display varieties of touch: but the term has been extended so as to include many irregular works, similar to the prelude, the fantasia, and the improvisation.
This word is Italian in origin, coming from the feminine past participle of 'toccare,' to touch.
Related